JEAN I LIU
CIK 1241357 · Chief Legal Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.8K
Companies
5
Total Filings
84
Lifetime Open-Market Net
-$22.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTB | Director | 11,779 | $2.36 | $27.8K | $0 | 2 | 2026-07-01 |
| ERAS | Director | — | $16.76 | — | $0 | 8 | 2026-06-29 |
| Seagen Inc. (SGEN) Delisted | Chief Legal Officer | 0 | $228.74 | $0 | -$22.94M | 52 | 2023-12-15 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | VP & General Counsel | 16,187 | — | — | $0 | 5 | 2014-02-10 |
| DURECT CORP (DRRX) Delisted | Chief Legal Officer | 18,463 | $1.91 | $35.3K | $0 | 11 | 2011-07-13 |
Recent Filings · Page 5 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-27 | Seagen Inc. (SGEN) Delisted | Grant (A) | +160 | $26.6K | EDGAR |
| 2021-09-02 | Seagen Inc. (SGEN) Delisted | Sell (S) | −3,648 | -$611.1K | EDGAR |
| 2021-08-18 | Seagen Inc. (SGEN) Delisted | Mixed | +8,528 | -$111.0K | EDGAR |
| 2021-05-13 | Seagen Inc. (SGEN) Delisted | Sell (S) | −1,061 | -$148.5K | EDGAR |
| 2021-02-18 | Seagen Inc. (SGEN) Delisted | Exer (M) | +4,846 | $200.5K | EDGAR |
| 2021-01-15 | Seagen Inc. (SGEN) Delisted | Mixed | — | -$720.2K | EDGAR |
| 2020-12-16 | Seagen Inc. (SGEN) Delisted | Mixed | +1,624 | -$741.2K | EDGAR |
| 2020-09-23 | Seagen Inc. (SGEN) Delisted | Exer (M) | +9,954 | $366.0K | EDGAR |
| 2020-09-16 | Seagen Inc. (SGEN) Delisted | Sell (S) | −11,610 | -$1.97M | EDGAR |
| 2020-09-02 | Seagen Inc. (SGEN) Delisted | Sell (S) | −3,648 | -$568.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.